Beyond Appetite: Discovering Hidden Opportunities in the GLP-1 Era
In just a few short years, GLP-1 receptor agonists have transformed from specialized diabetes medications to household names. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound dominate headlines, social media discussions, and increasingly, medicine cabinets across the country. While their weight loss benefits have captured public attention, the true revolution extends far beyond the bathroom scale. […]